Verastem Inc VSTM:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/25/22 EST
0.40quote price arrow up+0.014 (+3.6364%)
Close
0.385quote price arrow down-0.0062 (-1.5849%)
Volume
503,441
52 week range
0.29 - 2.79
Loading...
  • Open0.3999
  • Day High0.4067
  • Day Low0.382
  • Prev Close0.3912
  • 52 Week High2.79
  • 52 Week High Date11/26/21
  • 52 Week Low0.29
  • 52 Week Low Date10/21/22

Key Stats

  • Market Cap80.885M
  • Shares Out210.09M
  • 10 Day Average Volume1.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change-81.22

KEY STATS

  • Open0.3999
  • Day High0.4067
  • Day Low0.382
  • Prev Close0.3912
  • 52 Week High2.79
  • 52 Week High Date11/26/21
  • 52 Week Low0.29
  • 52 Week Low Date10/21/22
  • Market Cap80.885M
  • Shares Out210.09M
  • 10 Day Average Volume1.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change-81.22

RATIOS/PROFITABILITY

  • EPS (TTM)-0.40
  • P/E (TTM)-0.97
  • Fwd P/E (NTM)-0.92
  • EBITDA (TTM)-72.483M
  • ROE (TTM)-92.71%
  • Revenue (TTM)3.141M
  • Gross Margin (TTM)17.35%
  • Net Margin (TTM)-2,339.54%
  • Debt To Equity (MRQ)39.23%

EVENTS

  • Earnings Date03/19/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Verastem Inc

 

Profile

MORE
Verastem, Inc. is a biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition. Its advanced product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including, low-grade serous ovarian cancer (LGSOC)...
Brian Stuglik
Chief Executive Officer, Director
Daniel Paterson
President, Chief Operating Officer
Daniel Calkins
Interim Chief Financial Officer
Address
117 Kendrick St Ste 500
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
LGVN
Longeveron Inc
4.29+0.01+0.23%
IOBT
IO Biotech Inc
2.70+0.02+0.75%
ENLV
Enlivex Therapeutics Ltd
4.66-0.02-0.43%
DBTX
Decibel Therapeutics Inc
3.28+0.02+0.61%
MIRO
Miromatrix Medical Inc
4.02+0.12+3.08%